Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 5/2019

01-09-2019 | Breast Cancer | Correction

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

Authors: Norikazu Masuda, Hirofumi Mukai, Kenichi Inoue, Yoshiaki Rai, Shinji Ohno, Yuko Mori, Satoshi Hashigaki, Yasuaki Muramatsu, Yoshiko Umeyama, Hiroji Iwata, Masakazu Toi

Published in: Breast Cancer | Issue 5/2019

Login to get access

Excerpt

The correct name of the last author should be “Masakazu Toi”, and not ‘‘Masakuzu Toi” as given in the original publication of the article. …
Metadata
Title
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer
Authors
Norikazu Masuda
Hirofumi Mukai
Kenichi Inoue
Yoshiaki Rai
Shinji Ohno
Yuko Mori
Satoshi Hashigaki
Yasuaki Muramatsu
Yoshiko Umeyama
Hiroji Iwata
Masakazu Toi
Publication date
01-09-2019
Publisher
Springer Japan
Published in
Breast Cancer / Issue 5/2019
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-019-00984-1

Other articles of this Issue 5/2019

Breast Cancer 5/2019 Go to the issue

Original Article

Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy

Original Article

Lateral thoracoaxillar dermal-fat flap for breast conserving surgery: the changes of the indication and long-term results

Original Article

C677T and A1298C methylenetetrahydrofolate reductase polymorphisms and breast cancer susceptibility among Latinos: a meta-analysis

Original Article

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

Original Article

The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan

Original Article

Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits